Scroll to top
© 2020, Startuprecipe theme by Rssow

Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy

2023/02/21

Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy

– Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication – NEWTON, Mass. and FLORENCE, Italy, Feb. 21, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"),...

2023/02/21

LambdaTest launches visual regression testing platform SmartUI

Users can now automate visual regression testing in a single click across 3000+ different desktop and mobile environments to identify visual deviations SAN FRANCISCO, Feb. 21, 2023 /PRNewswire/ — LambdaTest, the leading digital experience testing cloud platform, has launched SmartUI,...

2023/02/21

Ridgewood Infrastructure and IDE Technologies Announce Water PPP with the City of Ft. Lauderdale

NEW YORK, Feb. 21, 2023 /PRNewswire/ — Ridgewood Infrastructure LLC ("Ridgewood"), a leading infrastructure investor in the U.S., and IDE Technologies, LTD. ("IDE"), a global leader in advanced water treatment, announce the closing of a public private partnership with the...

2023/02/21

Report on Digital Assets: Renewed Emphasis Towards Utility and Institutional Adoption

The report, jointly produced by Oliver Wyman, Elevandi and the Monetary Authority of Singapore, highlights that despite the wide-ranging and ongoing pressure facing the digital assets ecosystem, the downturn could mark an inflection point for the ecosystem. SINGAPORE, Feb. 21,...

2023/02/21

3 Highlights of Huawei's Green Intelligent OptiX Network will be unveiled at MWC 2023

BARCELONA, Spain, Feb. 21, 2023 /PRNewswire/ — Driven by the needs of the smart society, the bandwidth requirements of the campus, industrial interconnection, enterprise and home scenarios are increasing, and people’s demand for network connectivity is developing at a speed far...

2023/02/21

Tencent Cloud Ranks As The No. 1 Cloud Services Provider In Media Services Market, According To Frost & Sullivan

The APAC media services market size is projected to reach US$6,987 million in 2026, with a CAGR of 27% over the next four years Tencent Cloud is driving the APAC media services landscape helping enterprises to achieve "Immersive Convergence", accelerating...

2023/02/21

Panamax Inc., a Bankai Company, makes a Strategic Move for its Core Banking Solution: Acquires Acute Informatics

AHMEDABAD, India, Feb. 21, 2023 /PRNewswire/ — Panamax Inc., a Bankai Company and global Fintech development leader, recently announced that they had acquired Acute Informatics, an enterprise Digital Core Banking solution and IT Consulting company in Ahmedabad. The acquisition is...

2023/02/21

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/ — Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR)...

2023/02/21

TerraPay announces the strategic hire of Sudhesh Giriyan to lead the global remittance business

LONDON, Feb. 21, 2023 /PRNewswire/ — TerraPay, a leading global payments infrastructure company, announced the appointment of Sudhesh Giriyan as President & Global Head of Remittances, today. Strengthening the company’s senior leadership, this strategic appointment supports TerraPay’s continued global expansion....

2023/02/21

TCL Reiterates its Smart Manufacturing Commitments to Facilitate High-End Air Conditioning

HONG KONG, Feb. 21, 2023 /PRNewswire/ — TCL, one of the dominant players in the global TV industry and a leading consumer electronics brand, announces the Phase I completion of TCL Wuhan Intelligent Industrial Park, doubling down on smart manufacturing to...

2023/02/21

Omdia: The best-funded AI chip startups will face stress tests in 2023

LONDON, Feb. 21, 2023 /PRNewswire/ — Over 100 distinct venture capitalists (VCs) have invested over $6bn since 2018 into the top 25 artificial intelligence chip startups, according to Omdia’s new Top AI Hardware Startups Market Radar. However, while 2021 will...

2023/02/21

Mobileum Announces New Release of its Active Intelligence Platform

New version will support Mobileum’s end-to-end portfolio and enhance its Machine Learning capabilities to help CSPs cope with a rapidly evolving tech landscape CUPERTINO, Calif, Feb. 21, 2023 /PRNewswire/ — Mobileum Inc. ("Mobileum"), a leading global provider of telecom analytics solutions, is...

2023/02/21

Casio to Release Full-Metal G-SHOCK in Gleaming Yellow-Gold Hue

Introducing a New Color Option for the GM-B2100 Lineup of Full-Metal Watches with Octagonal Bezels TOKYO, Feb. 21, 2023 /PRNewswire/ — Casio Computer Co., Ltd. announced today the release of the latest addition to the G-SHOCK brand of shock-resistant watches....

2023/02/21

iGene Laboratory Announces Launch of Whole Exome Sequencing Service

SINGAPORE, Feb. 21, 2023 /PRNewswire/ — Singapore-based molecular diagnostics lab group iGene Laboratory announces the launch of FetalExome test service. FetalExome test is a whole exome sequencing (WES) test available for women with potentially complicated pregnancies. The test examines and analyses...

2023/02/21

Bridge Biotherapeutics Presents Phase 2a Clinical Trial Results For BBT-401, a Drug Candidate to Treat Ulcerative Colitis

BBT-401 meets safety endpoints achieved in previous clinical studies The drug candidate did not achieve an improved clinical response compared to the placebo study group 54.5% of the treatment cohort exhibited a valid treatment response to orally administered BBT-401 SEONGNAM,...

2023/02/21

Dubai International Finance Centre Grows at Record-Breaking Pace in 2022

Combined revenues exceed USD272 mn for the first time DUBAI, UAE, Feb. 21, 2023 /PRNewswire/ — Dubai International Financial Centre (DIFC), the Middle East, Africa and South Asia region’s leading global financial centre, continued to grow at record-breaking pace in...

Access to the latest Korean startup news and startup database for free

sign up for Startup Recipe newsletter